Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. See our mission Join us and change the world of medicine Life at Moderna So, what is mRNA? Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do.
- Career Opportunities
Moderna, Inc. | Home. Moderna, Inc. | Home
- About Us
About Us - Pioneering mRNA technology - Moderna
- Contact Us
Moderna only accepts invoices to Accounts Payable in PDF...
- Pipeline
Pipeline - Pioneering mRNA technology - Moderna
- The Science of mRNA
The Science of mRNA - Pioneering mRNA technology - Moderna
- Career Opportunities
Jun 10, 2022 · Moderna (Spikevax) COVID-19 vaccine received U.S. Food and Drug Administration (FDA) approval on January 31,2022, for individuals ages 18 years and older. Once vaccines are approved by the FDA, companies can market the vaccines under brand names. Spikevax is the brand name for the Moderna COVID-19 vaccine.
Moderna, Inc., ( / məˈdɜːrnə / mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response.
- September 2010; 11 years ago
- 200 Technology Square, Cambridge, Massachusetts, U.S.
- 2,700 (Dec 2021)
- Noubar Afeyan (12.7%), Stéphane Bancel (7.9%), Robert S. Langer (2.9%), Stephen Hoge (1.3%)
A series started with Moderna COVID-19 vaccine should be completed with this product. *An 8-week interval may be optimal for some people ages 12 years and older, especially for males ages 12 to 39 years. A shorter interval (3 weeks for Pfizer-BioNTech; 4 weeks for Moderna) between the first and second doses remains the recommended interval for:
1 day ago · Moderna originally asked the Food and Drug Administration to authorize its vaccine for adolescents ages 12 to 17 more than a year ago, but the regulator held off after other countries raised...